Catalyst Wire Dossier Catalyst Wire Dossier

NgG Gonorrhea Vaccine

NgG (Neisseria gonorrhoeae GMMA) vaccine · GlaxoSmithKline
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for NgG Gonorrhea Vaccine, covering 2025-08-07 to 2025-08-07. Get the full timeline:

Most recent: Clinical Trial Update: Safety and Efficacy of GSK Neisseria Gonorrhoeae GMMA (NgG) Investigational Vaccine When Administered to Healthy Adults 18 to 50 Years of Age. [Phase 1, Phase 2]

See pricing